Skip to main content

Topic

Pharmaceuticals

1,010 published works

  1. Inside EU Life Sciences

    Landmark UK-US Pharmaceutical Deal

    By Grant Castle, Raj Gathani, Dan Spivey

    On 1 December 2025, the UK Government announced a “landmark” UK-US pharmaceutical deal.   Under the deal, the UK claims to be (so far) the only country to secure zero-percent tariffs…

  2. International Trade Insights

    The US and UK Reach Agreement in Principle on Pharmaceuticals, Pharmaceutical Ingredients, and Medical Technology

    By Husch Blackwell Trade Team

    On December 1, 2025, the United States and United Kingdom announced an agreement in principal on pharmaceuticals, pharmaceutical ingredients, and medical technology. Under the agreement, the U.S. will: Exempt U.K.-origin…

  3. Regulatory Oversight

    Fourth Circuit Revives West Virginia Public Nuisance Suit Against Opioid Distributors

    By Barry Boise, Jeff Johnson, Jessica Birdsong, Lauren Fincher

    What Happened: A unanimous panel of the U.S. Court of Appeals for the Fourth Circuit revived a suit against certain pharmaceutical distributors brought under West Virginia public nuisance law. The…

  4. As Prescribed

    Major Overhaul of UK Rare Disease Regulation: MHRA Proposes Enhanced Framework

    By Morgan Lewis

    The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced its intention to introduce sweeping reforms for accelerating rare disease therapy development and approval, with the aim to position…

  5. Drug Injury Watch

    Wegovy and Ozempic Increase NAION Risk, an Eye Side Effect That Can Result in Blindness

    By Tom Lamb

    Semaglutide is the Active Ingredient in These GLP-1 Drugs Used for Diabetes or Weight Loss (Posted by Tom Lamb at Drug Injury Watch) Over the past year, we have written several articles that…

  6. TortsProf Blog

    Meier on Failure-to-Warn Suits Against Pharmaceutical Companies

    By Christopher Robinette

    Luke Meier has posted to SSRN Failure-to-Warn Suits Against Pharmaceutical Companies: Physician Testimony, Causation, and Summary Judgment. The abstract provides: It is hard to win a tort suit against a…

  7. Global Supply Chain Compliance

    Healthcare & Life Sciences Supply Chains Series: Achieving Stability Through Innovation and Compliance (3 of 4)

    By Publisher

    As supply chains shift and vendor arrangements evolve in response to tariffs, life sciences companies must adapt to increasingly intricate and intertwined challenges across operational and commercial needs. Manufacturing relocation,…

  8. Global Policy Watch

    Germany enacts Standard Contractual Clauses for pharmaceutical clinical trial agreements – Changes for medical device studies also on the horizon

    By Dr. Dr. Adem Koyuncu, Maximilian Aretz

    Germany has taken another step to improve the conditions for pharmaceutical research & development in Germany. Now, the Federal Government has adopted the “Standard Contractual Clauses” for pharmaceutical clinical trial…

  9. Delaware Corporate & Commercial Litigation Blog

    Chancery Court lets bankruptcy admin press suit against ex-pharma D&Os

    By Francis Pileggi

    Frank Reynolds, who has been covering Delaware corporate decisions for various national publications for over 40 years, prepared this article. The Court of Chancery recently refused to dismiss most of…

  10. Elder Law Prof Blog

    Recent News Articles for Law Students to Consider When Looking for Legal Research Topics with Significance in an Aging World

    By Katherine C. Pearson

    It is the time of year when law students often stop by my office for a visit to explore possible ideas for their case notes for law review or for…